The most common mistake in a barrier cream brief is naming a ceramide percentage & stopping there. The percentage is the easy part to write & the least useful part to specify, because a cream carrying a fraction of a per cent of a single ceramide in a poorly matched lipid environment can feel worse on the skin than a simpler cream with no ceramide story at all. What decides the sensory result is the relationship between the lipids, the state they are in inside the emulsion, & the emulsifier holding the whole thing together.
This article works through how a barrier cream is actually constructed, from the ceramide type & its naming through the cholesterol & fatty acid partners, the ratio question, the dissolution step that decides whether the product grains on the shelf, the emulsifier that has to form a lamellar structure, the preservation window, & the pack that protects it all. It closes on the wording a brand can print & the wording it cannot, because barrier is one of the categories where a hopeful sentence on the artwork creates the largest problem later.
Why a barrier brief starts with the lipid system
A moisturiser brief usually opens with texture & a target consumer, & the actives are slotted in afterwards. A barrier brief has to open with the lipid system, because the lipids are not a garnish in this category: they are the structure. Ceramides, cholesterol & free fatty acids are waxy or crystalline solids at room temperature, & how they are dissolved, dispersed & then re-solidified inside the emulsion decides whether the finished cream is smooth, grainy or split.
The practical consequence is that the brief has to say more than a percentage. It has to say whether the ceramide is the headline active or one of several lipids, whether the brand wants an occlusive film or a light lotion, & whether the product is intended for daily use or for a flare-up week. Those three answers change the oil phase, the emulsifier, the fatty alcohol level & the pack, & a factory that receives only a percentage will make reasonable choices that may not be the ones the brand imagined.
There is a commercial reason to settle this early as well. Ceramides are among the more expensive raw materials a face cream will contain, & the cost sits in the formula rather than in the pack or the labour. Substituting a cheaper lipid for a headline ceramide reduces the unit cost without changing the ingredient list a consumer reads, & that is a decision the brand should make deliberately rather than discover in a quotation.
What ceramides are, & what the name tells you
A ceramide is a sphingoid base joined to a fatty acid by an amide bond. Both halves vary, & the letters after the word ceramide on an ingredient list encode which version is present. A name ending in NP, for instance, describes a particular pairing of a non-hydroxy fatty acid with phytosphingosine, while AP indicates an alpha-hydroxy fatty acid, & EOP indicates an ester-linked omega-hydroxy fatty acid. Older literature & some supplier documents still use the numbered names such as ceramide 3 or ceramide 6, which map onto the same molecules.
This matters to a brand for two reasons. First, a formula that cites ceramides but does not say which ones is not a specification, & a quotation built on it is not comparable with another quotation built on a different blend. Second, different ceramide types behave differently in the melt, so the dissolution temperature & the cooling profile have to be set against the specific blend rather than against the word ceramide in general.
There is also an origin question. Ceramides can be produced by fermentation routes or derived from plant materials, & the two are not always interchangeable at the same use level. A brand that markets a vegan or plant-derived position needs the origin stated in writing at the brief stage, because the substitution is not something a formulator can make silently without changing the story on the pack.
Cholesterol, fatty acids & the ratio that matters
Ceramides do not work alone in the skin, & the literature describes them alongside cholesterol & free fatty acids as the three principal lipid classes of the outer skin layer. A cream that adds a ceramide without any partner lipid is not reproducing that relationship. It is adding one ingredient to a base, which may still be a perfectly good moisturiser, but it is a different product from a cream built around a lipid system.
The ratio question is where most of the argument sits. The published work describes an approximately equimolar relationship between the three classes, while a ceramide-dominant ratio of roughly three parts ceramide to one part cholesterol to one part fatty acid appears repeatedly in the dermatological literature & in supplier material. A brand does not need to resolve that debate to write a brief, but it does need to know which view it is buying, because the two give very different formulas at the same total lipid level.
Two practical points follow. The headline percentage of ceramide is less informative than the ratio between the three classes, because a cream with a high ceramide figure & no partner lipids is not the same proposition as a cream with a lower figure inside a balanced lipid mix. The fatty acid choice is not neutral either: stearic & palmitic acids bring structure, while more fluid unsaturated acids change the melt & the feel, so the acid selection is part of the design rather than a filler.
Cholesterol itself has a sourcing question. It can come from lanolin or from plant sterols, & a brand with a plant-based position will want the plant route stated explicitly, because cholesterol derived from wool fat is not acceptable to every audience regardless of how well it performs. Asking for the source in writing removes an assumption that is easy to make & expensive to reverse after the artwork is printed.
Getting ceramides into an emulsion without recrystallisation
Ceramides are waxy solids with a high melt point, & that single fact drives the hardest part of the process. They have to be fully dissolved in the oil phase at a temperature high enough to clear all crystallinity, then held there long enough for the solution to be uniform before the emulsion is formed. A ceramide that is only partly dissolved becomes nuclei for crystals during cooling, & the result is a cream that feels slightly gritty, or one that develops a grain after a few weeks in a warm warehouse.
The usual answers are a higher oil-phase temperature, a longer hold, & in many cases a pre-made lipid concentrate in which the ceramide, the cholesterol & the fatty acid are already blended & solubilised by the supplier. Concentrates remove a large part of the risk because the difficult dissolution has been done under controlled conditions, but they add cost & they fix the ratio, which may not suit a brand that wants a specific lipid relationship.
Cooling is the other half of the problem. A fast cool through the crystallisation range can trap a disordered structure that later rearranges in the pack, which is why some creams change texture between the first week & the third month. A controlled cooling ramp, documented with the target temperatures & the agitation profile, is the factory-side answer, & it is worth asking how the batch record captures it rather than assuming it is done by feel.
Choosing an emulsifier for a lamellar cream
A barrier cream usually performs best with an emulsifier system that builds a lamellar structure, meaning the surfactant molecules arrange in layers that mimic the organised lipid arrangement of skin rather than in a simple droplet shell. That layered arrangement is what gives the cream its cushion, its slow rub-in & its ability to hold a large amount of fatty alcohol without feeling waxy. It is also what makes the texture so sensitive to the emulsifier pair.
The familiar route is a fatty alcohol combined with a nonionic or anionic emulsifier, at levels far above what a light lotion would need. The fatty alcohol is not there as a thickener in the usual sense; it is a structural partner that participates in the layered arrangement. Reduce it to fix a viscosity problem & the structure thins; raise the emulsifier to compensate & the cream turns soapy or stingy on sensitive skin.
This is the point at which an inexpensive emulsifier choice becomes expensive. A cheap system can be made to work in a simple lotion, but in a lipid-rich cream it often produces an unstable emulsion that separates under temperature cycling, & the recovery route is a reformulation rather than an adjustment. The emulsifier is a small share of the formula cost & a large share of the risk, which is an unusual combination worth remembering when comparing quotations.
Texture routes: cream, balm, lotion & ointment-style
The four routes a barrier product usually takes are an emulsion cream, an anhydrous balm, a lighter lotion & a heavy ointment-style base, & each one solves a different problem. The emulsion cream is the general-purpose answer, offering a cushion & a familiar feel. The anhydrous balm avoids water altogether, which removes the preservation question but produces a film that some consumers find heavy on the face, & a balm is usually a night product rather than a morning one.
A light lotion suits oily or combination skin that still reacts to actives, but the lower oil phase limits how much lipid the formula can carry before it stops feeling light. The ointment-style base sits at the other extreme, with a high occlusive content & a strong film, & while it is the most protective of the four it is also the least wearable under makeup. Choosing between them is a positioning decision as much as a formulation one.
The route also decides the pack. A balm needs a jar or a wide-orifice tube because the product cannot be pumped. An ointment-style base at high viscosity needs a pack that lets the consumer extract it in a controlled amount, or the first use ends with too much product on the fingers. A lotion belongs in a pump. Naming the route in the brief lets the factory propose a pack that matches rather than a pack that has to be redesigned after the sample.
Preservation & pH: where barrier formulas go wrong
Barrier creams sit in an awkward place for preservation. They contain water, so they need a preservation system & a challenge test, but they also carry a high lipid load & a pH that is often set near skin values rather than at the lower end where some weak-acid preservatives work best. The result is a narrower choice of systems & a greater need to test the finished formula rather than a model base.
pH also affects the lipids themselves. The amide bond in a ceramide is not indefinitely stable, & a formula driven to an extreme pH for another reason can put the lipid system under avoidable stress over a two-year shelf life. A moderate pH window, checked at the start & the end of the stability study, is the practical safeguard, & the brief should state whether the pH target is a range or a single value.
There is a further risk that arrives with the actives rather than the lipids. Niacinamide, certain vitamin C salts & other water-soluble actives bring electrolytes, & electrolytes can destabilise both the emulsifier system & the preservative. A barrier cream that combines ceramides with a high-dose salt active is a harder brief than it looks, & the factory should be told about the active load before the base is chosen rather than after the first sample separates.
Packaging: airless, tube or jar for a lipid-rich cream
A lamellar cream is a structured system, & the pack either preserves that structure or works against it. A jar exposes the whole batch to air on every use, invites finger contact & allows the surface to dry & skin over, which a consumer reads as the product changing. An airless pump or a well-selected tube protects the bulk & delivers a controlled dose, which suits a rich cream that a consumer will use in small amounts.
Airless is not automatic. The base has to be pumpable at the viscosity it settles to, & a very heavy ointment-style base may not dispense well from a small airless pack. A tube with an orifice matched to the viscosity is often the better compromise, & the orifice diameter is a specifiable detail that changes the dose per squeeze more than most brands expect. Testing the bulk in the actual component before the run is the step that settles it.
The pack also interacts with the claim. A jar invites the consumer to take more product than needed, which makes a rich cream feel wasteful, while a pump dispenses a controlled amount & supports a premium price position. For a cross-border seller watching landed cost, the pack is also a large share of the unit price & a large share of the freight, so a heavier glass jar with a heavy cap can move the landed figure more than a change of emulsifier ever will.
Fragrance, allergens & the flash-point question
Barrier products are bought by people whose skin is reactive, which makes fragrance the most contested line in the brief. A fragrance can cover the faint odour of the lipid system & make the product feel more finished, but it also adds an allergen declaration duty & a small but real risk of a reaction in exactly the audience the product is aimed at. Many brands in this category choose fragrance-free & say so on the front of the pack.
Where a fragrance is present, the IFRA 26-allergen declaration has to be handled properly. The declaration names the fragrance constituents that require labelling above their threshold, & the document comes from the fragrance house rather than from the finished goods factory. A brand should expect the allergen list & the IFRA certificate as part of the technical file before the artwork is finalised, because the allergen names have to appear on the label in some markets & the space on a small tube is limited.
There is also a transport question that catches out brands who add a fragrance late. Fragrance concentrates & any alcohol used in the formula carry a flash point, & a low flash point changes the transport classification of the finished goods & can restrict air freight. This is not usually a problem for a water-based cream with a small fragrance load, but it has to be checked rather than assumed, & the safety data sheet for the bulk should state the position before goods are booked.
What wording about the barrier can & cannot carry
The words a brand can print on a barrier cream fall into two groups, & the line between them is not always obvious to a marketer. Describing what the product does cosmetically is straightforward: moisturising, softening, smoothing, comfortable, gentle, suitable for dry skin. These are functional descriptions of a cosmetic effect, & they are the safe vocabulary of the category in most markets.
What cannot be said is anything that suggests the product addresses a skin condition. Wording that implies the cream handles eczema, dermatitis, rosacea, infection or any other diagnosed state moves the product across the boundary between a cosmetic & a medicinal product, & the consequences of crossing that line fall on the brand that owns the label. Phrases that promise to rebuild, restore or regenerate skin structure sit in the same dangerous zone, because they imply a change to living tissue rather than an effect on the surface.
Between those two groups sits the wording most brands actually want, such as supporting the skin barrier or caring for a compromised barrier. That language is used widely & is defensible where the brand can show a reasonable basis for it, which in practice means a test protocol & a dossier that a reviewer could inspect. The useful discipline is to decide the wording before the testing is commissioned, so the study is designed to support the sentence that will appear on the pack, rather than commissioning a study & then writing whatever the result seems to allow.
Lipid system approaches compared
The table below sets out the routes a barrier cream usually takes, what each one contains, where it fits & what the brief has to settle for it. It is a comparison of approaches rather than a set of recommended levels, & the levels themselves are fixed at the bench against the texture target & the cost ceiling.
| Lipid approach | What it contains | Where it fits best | What the brief has to settle |
|---|---|---|---|
| Single ceramide in a simple cream | One ceramide type at a low level | A first barrier product with a modest price point | Whether the claim rests on the lipid system or on the base |
| Ceramide blend, no partner lipids | Two or three ceramide types | Brands that want a ceramide story without a full system | How the blend is melted & held before emulsification |
| Ceramide, cholesterol & fatty acid mix | All three lipid classes | A positioned barrier product with a technical story | The ratio between the classes, not just the headline dose |
| Ceramide-dominant ratio style base | Ceramide weighted against the partners | Premium barrier positioning with testing behind it | Which published ratio the brand intends to follow, in writing |
| Ceramide-like amide instead of a ceramide | A synthetic amide with similar behaviour | Cost-controlled ranges & some plant-based positions | Whether the pack wording can still say ceramide |
| Phytosterol blend used for the cholesterol part | Plant sterols replacing animal-derived sterol | Vegan & plant-positioned brands | Sourcing statement in writing & any certification route |
| Anhydrous balm with ceramides | Waxes, butters & lipids, no water | Night care & very dry skin formats | Feel target, since there is no water phase to lighten it |
| Ointment-style high-occlusive base | Heavy occlusive with a small lipid system | Maximum protection & post-procedure style positioning | Wearability, pack type & how the consumer doses it |
None of these rows is better than another in isolation. A brand selling into a market where the consumer reads an ingredient list will want the depth of the third or fourth row, while a brand competing on price at a mass channel may be better served by the first, provided the wording on the pack does not promise more than the system delivers. Matching the row to the channel is the decision that matters.
What to put in the brief
Give the factory the lipid system, the texture target & the claim in the same document, because in this category the three are linked. State which ceramide types you are open to & whether you have a fixed ratio in mind, name the partner lipids & their sourcing position, & say whether the product is a daily cream, a night balm or a light lotion. Then add the constraint that decides the quotation: the cost ceiling per unit that the channel can carry.
- The ceramide types & whether a specific ratio between the lipid classes is required.
- The sourcing position: animal-derived, plant-derived or fermentation route.
- The texture route, meaning cream, lotion, balm or ointment-style.
- The intended claim wording, so the test protocol can be built to support it.
- The pH target as a range, & whether it is fixed by an active in the formula.
- The other actives & their salt forms, because the electrolyte load is a stability risk.
- The pack type, the dose per use & whether a jar is acceptable to the brand.
- The first order volume, the cost ceiling per unit & the launch date.
Then settle the evidence question before sampling rather than after. If the pack will carry wording about the barrier, the brand should know which test protocol will support it, who commissions it, when it runs & what the file will hold. A brand that orders a cream first & asks about the study afterwards usually ends up either weakening the wording or paying for a second round of testing on a formula that is already packed.
Where our capability fits
We build barrier creams from the lipid system outward, which means the melt & hold conditions for the ceramide blend, the cooling ramp through the crystallisation range & the emulsifier pair are all chosen against the specific lipids rather than against a generic cream template. The batch record captures the process temperatures & the agitation profile, so a second order reproduces the first by reference instead of by memory, & the finished bulk is stored in the intended component during stability work so the pack is tested rather than assumed.
We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing & full custom formula development, & we will tell you at the brief stage whether the wording you want can be supported by the evidence route you are willing to pay for. Adjacent lines include a hydrating soothing repair face cream & a ceramide moisturising capsule essence, produced under the same lipid handling & retention discipline.
Tell us the lipid system you have in mind, the texture you want & the sentence you intend to print, & we will come back with a base proposal, the pack options that protect it & the stability route it implies. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319. For the surrounding background, see our ceramide & sensitive skin formulation guide & our article on stability studies & shelf life.
General manufacturing information, not regulatory or legal advice. Ingredient permitted lists, claim wording rules, allergen labelling thresholds & transport classification vary by market & by product, & the applicable requirements should be confirmed for each destination before a product is placed on sale.